BEC » Topics » Chemistry Systems

This excerpt taken from the BEC 10-K filed Feb 29, 2008.

Chemistry Systems

Revenue was down in Chemistry Systems by 1.7% in 2006. The decrease in chemistry revenue is due primarily to the shift to OTL customer contracts. Hardware revenue for this product line is one of the areas most affected by the leasing policy change. Pricing declines were more than offset by increased utilization of reagents on newer systems due to reagent capacity and productivity enhancements. We had a second record year in new placements of our chemistry systems lead by the SYNCHRON® Unicel® DxC 600 and 800 systems and our new chemistry/immunoassay 2nd generation work cell, the DxC 600i.

This excerpt taken from the BEC 10-Q filed Nov 7, 2007.

Chemistry Systems

Revenue increased in Chemistry by 6.3% and 9.9% for the three and nine months ended September 30, 2007, respectively, due primarily to:

 

 

·

 

continued placements of our UniCel® DxC 600 and 800 systems,

 

 

·

 

strong placements of our new second generation chemistry/immunoassay work cell, the UniCel® DxC 600i, and

 

  ·  

increased utilization of chemistry consumables on newer systems due to reagent capacity and productivity, which offsets pricing and volume declines experienced in dedicated proteins and certain other reagents.

This excerpt taken from the BEC 10-Q filed Aug 7, 2007.

Chemistry Systems

Revenue increased in Chemistry Systems by 14.0% and 11.8% for the three and six months ended June 30, 2007, respectively, due primarily to:

 

  ·  

Continued placements of our SYNCHRON UniCel DxC 600 and 800 systems,

 

  ·  

Strong placements of our new second generation chemistry/immunoassay work cell, the DxC 600i, and

 

  ·  

Increased utilization of reagents on newer systems due to reagent capacity and productivity, which offsets pricing and volume declines experienced in dedicated proteins and certain other reagents.

This excerpt taken from the BEC 10-Q filed May 8, 2007.

Chemistry Systems

Revenue increased in Chemistry Systems by 9.4% for the three months ended March 31, 2007 due primarily to:

 

  ·  

growth in consumables revenue due to new placements,

 

  ·  

increased utilization of reagents on newer systems due to reagent capacity and productivity, which offsets pricing and volume declines experienced in dedicated proteins and certain other reagents, and

 

  ·  

continued placements of our SYNCHRON® UniCel® DxC 600 and 800 systems and our new second generation chemistry/immunoassay work cell, the DxC 600i.

This excerpt taken from the BEC 10-K filed Feb 26, 2007.

Chemistry Systems

Revenue was down 2.3% in 2005 due primarily to the mid year change in emphasis to OTL customer contracts as this product area is one of the most affected by the leasing policy change. Placements of our new Unicel® DxC 600 and 800 SYNCHRON® systems outperformed our expectations and contributed to increased year-over-year system placements in Chemistry Systems. As a result of the unit placements, we also generated more consumables revenue in this product area. Consumables revenue for this product line grew 5.5% in 2005. Partially offsetting our growth in chemistry consumables was the impact of raw material supply problems with certain reagents. We have taken steps to address and resolve these issues.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki